摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[2-[dimethyl(methylidene)-lambda5-phosphanyl]ethyl]oxolane-3,3,4-triol

中文名称
——
中文别名
——
英文名称
(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[2-[dimethyl(methylidene)-lambda5-phosphanyl]ethyl]oxolane-3,3,4-triol
英文别名
(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[2-[dimethyl(methylidene)-λ5-phosphanyl]ethyl]oxolane-3,3,4-triol
(2R,4R,5R)-2-(7-aminoimidazo[4,5-b]pyridin-3-yl)-5-[2-[dimethyl(methylidene)-lambda5-phosphanyl]ethyl]oxolane-3,3,4-triol化学式
CAS
——
化学式
C15H23N4O4P
mdl
——
分子量
354.34
InChiKey
FCKHYNYLXHZIIR-MPKXVKKWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.6
  • 重原子数:
    24
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.53
  • 拓扑面积:
    127
  • 氢给体数:
    4
  • 氢受体数:
    7

文献信息

  • MODIFIED POLYNUCLEOTIDES ENCODING ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR
    申请人:MODERNA THERAPEUTICS, INC.
    公开号:US20140161873A1
    公开(公告)日:2014-06-12
    The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
  • MODIFIED POLYNUCLEOTIDES ENCODING CITED4
    申请人:MODERNA THERAPEUTICS, INC.
    公开号:US20140186432A1
    公开(公告)日:2014-07-03
    The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
  • IN VIVO PRODUCTION OF PROTEINS
    申请人:Moderna Therapeutics, Inc.
    公开号:US20150111248A1
    公开(公告)日:2015-04-23
    The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
  • MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF BIOLOGICS AND PROTEINS ASSOCIATED WITH HUMAN DISEASE
    申请人:Moderna Therapeutics, Inc.
    公开号:US20160075733A1
    公开(公告)日:2016-03-17
    The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules.
  • MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF
    申请人:Moderna Therapeutics, Inc.
    公开号:US20160354491A1
    公开(公告)日:2016-12-08
    The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using them.
查看更多